The Stunning Golden Parachutes of Juno's $9B Celgene Deal Post author:Sam Post published:February 4, 2018 Post category:BioPharma Juno’s Hans Bishop will take home $287M after Celgene acquired his company. Source: BioSpace You Might Also Like New Jersey Startup Launches With Clinical Assets From Big Name Biotechs August 21, 2017 Pfizer Turns to to Explore $2 Billion Sale of Certain Assets February 1, 2017 Bay Area's E-Scape Bio Bursts Out of Stealth Mode With $63 Million to Tackle Alzheimer's July 11, 2017
Bay Area's E-Scape Bio Bursts Out of Stealth Mode With $63 Million to Tackle Alzheimer's July 11, 2017
